KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Tae Won Kim

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 28건 중 1-28 번을 표시중입니다.

1 Article Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors : A Phase 1a/1b Nonrandomized Controlled Trial Tae Won Kim ; Philippe L. Bedard ; Patricia LoRusso ; et al 2023
2 Article CEA dynamics for predicting response after anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer Sora Kang ; Sun Young Kim ; Yong Sang Hong ; et al 2023
3 Article CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer Dong-In Koh ; Ji Hee Gong ; DO Yeon Kim ; et al 2022
4 Article Clinical outcomes of curative surgical resection of peritoneal metastasis in patients with colorectal cancer: A long-term follow-up study Kyunghye Bang ; Jeong Eun Kim ; Tae Won Kim ; et al 2023
5 Article Clinicogenomic Characteristics and Treatment of Young-Onset Colorectal Cancer Patients Treated With Palliative Therapy in Real-World Practice Hyehyun Jeong ; Eunjung Lee ; Deokhoon Kim ; et al 2022
6 Article Comprehensive evaluation of the tumor immune microenvironment and its dynamic changes in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy: From the phase II ADORE study Hyungwoo Cho ; Jeong Eun Kim ; Yong Sang Hong ; et al 2022
7 Article Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment Hyung-Don Kim ; Sun Young Kim ; Jihun Kim ; et al 2022
8 Article Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance Eunyoung Tak ; Minhee Kim ; Youngra Cho ; et al 2022
9 Article FDG metabolic parameter-based models for predicting recurrence after upfront surgery in synchronous colorectal cancer liver metastasis Hyo Sang Lee ; Hyun Woo Kwon ; Seok-Byung Lim ; et al 2023
10 Article First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors Tae Won Kim ; Howard A Burris ; Maria J de Miguel Luken ; et al 2022
11 Article First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors Filip Janku ; Seung-Hoon Beom ; Yong Wha Moon ; et al 2022
12 Article Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability‒High Colon Cancer Jaewon Hyung ; Eun Jeong Cho ; Jihun Kim ; et al 2022
13 Article Immune Profile of BRAF-Mutated Metastatic Colorectal Tumors with Good Prognosis after Palliative Chemotherapy Jeong Eun Kim ; Ji-Hun Kim ; Sang-Yeob Kim ; et al 2022
14 Article Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study Satoru Iwasa ; Zi‐Xian Wang ; Kei Muro ; et al 2023
15 Article Involvement of tissue changes induced by neoadjuvant treatment in total mesorectal excision (TME): novel suggestions for determining TME quality Jin Cheon Kim ; Seong Ho Park ; Jihun Kim ; et al 2022
16 Article KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Thierry André ; Filippo Pietrantonio ; Antonio Avallone ; et al 2023
17 Article Molecular characterization of dysplasia-initiated colorectal cancer with assessing matched tumor and dysplasia samples Sungwon Jung ; Jong Lyul Lee ; Tae Won Kim ; et al 2022
18 Article Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07 Seung Tae Kim ; Sun Young Kim ; Jeeyun Lee ; et al 2022
19 Article Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164 Dung T Le ; Luis A Diaz Jr ; Tae Won Kim ; et al 2023
20 Article Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer Takayuki Yoshino ; Thierry Andre ; Tae Won Kim ; et al 2023
21 Article Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability-high/mismatch repair-deficient or POLE-mutated metastatic or unresectable colorectal cancer Chung Ryul Oh ; Jeong Eun Kim ; Yong Sang Hong ; et al 2022
22 Article Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study Tsai-Sheng Yang ; Hong-Hwa Chen ; Lin Bo-Wen ; et al 2023
23 Article Radiofrequency Ablation versus Stereotactic Body Radiation Therapy in the Treatment of Colorectal Cancer Liver Metastases Jesang Yu ; Dong Hwan Kim ; Jungbok Lee ; et al 2022
24 Article Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group Shinkyo Yoon ; Miso Kim ; Yong Sang Hong ; et al 2022
25 Article Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial. Marwan G Fakih ; Scott Kopetz ; Yasutoshi Kuboki ; et al 2022
26 Article The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study Jwa Hoon Kim ; Seyoung Seo ; Jee Hyun Kim ; et al 2022
27 Article Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer Lucia Taraborrelli ; Yasin Şenbabaoğlu ; Lifen Wang ; et al 2023
28 Article Whole-genome sequencing reveals an association between small genomic deletions and an increased risk of developing Parkinson’s disease Ji-Hye Oh ; Sungyang Jo ; Kye Won Park ; et al 2023

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.